Commodore Capital’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Commodore Capital’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-383,638	Closed	-$23.9M	–	42
2023 Q4	$23.9M	Buy	383,638 +94,727	+33%	+$2.35M	2.08%	18
2023 Q3	$6.41M	Buy	+288,911	New	+$6.07M	0.75%	26

Commodore Capital's RYZB Position: Q1 2024 in Review

Commodore Capital sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 383,638 shares — an estimated $23.9M sold.

Commodore Capital first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $23.9M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Commodore Capital reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Commodore Capital sold 383,638 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $23.9M.
Commodore Capital first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Commodore Capital's RayzeBio, Inc. Common Stock position peaked at $23.9M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Commodore Capital's 13F filing for Q1 2024, filed 15 May 2024.